Institutional & Specialty Sales Consultant - Stroke/Thrombosis | New Castle, DE

A Pharmaceutical Sales Representative role focused on launching and promoting Asundexian, a stroke prevention therapy, within the neurology and thrombosis market, covering New Castle, DE.

Location: New Castle, DE

Salary: $124,320 - $186,480 per year, plus potential bonuses or commissions

Responsibilities

• Drive clinical demand, education, and sales by communicating the value of Asundexian in stroke prevention
• Lead formulary access by navigating P&T committees and influencing protocol adoption across health systems
• Build strategic relationships with priority institutions, including key stakeholders and neurologists
• Develop territory business plans based on local market insights and collaborate with internal teams for a successful launch
• Demonstrate expertise and knowledge of disease state, marketplace, competitors, and industry, with analytical skills to identify opportunities and challenges
• Analyze competitive landscape and proactively identify opportunities and risks

Requirements

• Bachelor's degree or 10 years of relevant sales experience in competitive landscapes
• Experience selling into hospitals, health systems, or institutional accounts
• Strong communication, presentation, and stakeholder engagement skills
• Ability to meet customer credentialing and safety requirements
• Valid driver’s license with a clean driving record

Benefits

• Top-tier compensation, healthcare coverage, and financial security programs including 401(k) with up to 10% company contributions, Employee Stock Purchase Plan, and Retiree Medical Account
• Paid parental leave, fertility benefits, and adoption support
• Employee discount on Bayer Consumer Health products
• Robust performance-driven quarterly incentive

Additional Information

• This role is region-specific to New Castle, DE, and candidates must be domiciled within the territory.
• The salary range is an estimate and may vary based on location, experience, and other factors.
• Application deadline is at least June 5, 2026.